Jörg Trojan
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 2%
- MicroRNA in disease regulation
Papers in
- Hepatology 65
- Hepatocellular Carcinoma Treatment and Prognosis 57
- Liver physiology and pathology 17
- Oncology 59
- Pancreatic and Hepatic Oncology Research 22
- Colorectal Cancer Treatments and Studies 17
- Co-authors
- Stefan Zeuzem (49 shared papers)Oliver Waidmann (20 shared papers)Albrecht Piiper (8 shared papers)Bernd Kronenberger (9 shared papers)Masatoshi Kudo (7 shared papers)Fabian Finkelmeier (15 shared papers)Javier Sastre (3 shared papers)Hyun Cheol Chung (3 shared papers)
- Journals
- Annals of Oncology (11 papers)Journal of Clinical Oncology (9 papers)Journal of Hepatology (7 papers)Cancers (5 papers)Endoscopy (5 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Jörg Trojan
145 papers receiving 3.3k citations
Jörg Trojan's Hit Papers
Peers
Comparison fields: 5 of 111
- Hepatology 1.3k
- Cancer Research 771
- Oncology 1.2k
- Pathology and Forensic Medicine 751
- Pulmonary and Respiratory Medicine 708
Countries citing papers authored by Jörg Trojan
This map shows the geographic impact of Jörg Trojan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Trojan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Trojan more than expected).
Fields of papers citing papers by Jörg Trojan
This network shows the impact of papers produced by Jörg Trojan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Trojan. The network helps show where Jörg Trojan may publish in the future.
Co-authors
The 25 scholars most cited alongside Jörg Trojan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 154 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial Hit paper breakdown → | 2015 | 634 |
| 2 | 2016 | 171 | |
| 3 | 2013 | 154 | |
| 4 | 2005 | 135 | |
| 5 | 2011 | 116 | |
| 6 | 2011 | 92 | |
| 7 | 2009 | 79 | |
| 8 | 2009 | 75 | |
| 9 | 2020 | 72 | |
| 10 | 2014 | 67 | |
| 11 | 2018 | 66 | |
| 12 | 2000 | 59 | |
| 13 | 2013 | 55 | |
| 14 | 2005 | 54 | |
| 15 | 2016 | 51 | |
| 16 | 1997 | 39 | |
| 17 | 2021 | 37 | |
| 18 | 2011 | 37 | |
| 19 | 2018 | 37 | |
| 20 | 2001 | 37 |
About Jörg Trojan
Jörg Trojan is a scholar working on Hepatology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 154 papers that have together received 3.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (57 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (25 papers), Genetic factors in colorectal cancer (22 papers), Gallbladder and Bile Duct Disorders (22 papers), Pancreatic and Hepatic Oncology Research (22 papers), Liver physiology and pathology (17 papers), Colorectal Cancer Treatments and Studies (17 papers) and Cancer Mechanisms and Therapy (16 papers). The work is most often cited by research in Hepatology (1.3k citations), Cancer Research (771 citations), Oncology (1.2k citations), Pathology and Forensic Medicine (751 citations) and Pulmonary and Respiratory Medicine (708 citations). Jörg Trojan has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Stefan Zeuzem, Oliver Waidmann, Albrecht Piiper, Bernd Kronenberger, Masatoshi Kudo, Fabian Finkelmeier, Javier Sastre, Hyun Cheol Chung, Takuji Okusaka and Davide Pastorelli. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Journal of Hepatology, Cancers and Endoscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.